Consolidated Financial Results for the Six-month Period Ended September 30, 2021

On October 29, 2021 NEC reported that (Press release, NEC, OCT 29, 2021, View Source com/en/press/202110/global_20211029_01.html [SID1234592188])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

1. Consolidated Financial Results for the Six-month Period Ended September 30, 2021 (April 1, 2021 – September 30, 2021)
(1) Consolidated Operating Results (Percentage indicate year-on-year changes.)
2. Dividends

3. Consolidated Financial Results Forecast for the Year Ending March 31, 2022 (April 1, 2021 – March 31, 2022)
1. Condensed Interim Consolidated Financial Statements and Notes to Condensed Interim Consolidated Financial Statements